BlueStreams Group
Request Information

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research

Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk.  Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform's AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients' cardiovascular risk better than the best clinical standards.  Read this case study for lessons learned.

View In New Tab

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research published by BlueStreams Group

BlueStreams Group partners with leaders in business to tackle their most important IT challenges and capture their greatest opportunities. Our diverse teams bring deep industry and functional expertise and range of skillsets to spark impactful change through leading edge management and IT consulting, as well as data science, design, and business purpose. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization to deliver practical results that help our clients thrive.